About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

SanBio Company Limited(4592) Summary

4592
TSE Growth
SanBio Company Limited
1,627
JPY
-51
(-3.04%)
Apr 4, 3:30 pm JST
11.13
USD
Apr 4, 2:30 am EDT
Result
PTS
outside of trading hours
1,582
Apr 4, 9:38 pm JST
Summary Chart Historical News Financial Result
PER
PBR
75.4
Yield
ー%
Margin Trading Ratio
159.54
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
1,680 JPY 11.48 USD
Previous Close Apr 3
1,678 JPY 11.39 USD
High Apr 4, 9:15 am
1,766 JPY 12.06 USD
Low Apr 4, 2:07 pm
1,583 JPY 10.85 USD
Volume
4,774,300
Trading Value
7.99B JPY 0.05B USD
VWAP
1672.79 JPY 11.46 USD
Minimum Trading Value
162,700 JPY 1,113 USD
Market Cap
0.12T JPY 0.80B USD
Number of Trades
12,948
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
High
1-Year Average
4,558
1-Year High Jun 17, 2024
60,960
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 5,300 5,184,500 978.21
Mar 21, 2025 6,900 4,957,500 718.48
Mar 14, 2025 100 5,364,000 53640.00
Mar 7, 2025 0 5,583,000
Feb 28, 2025 100 5,560,300 55603.00
Company Profile
SanBio Company Limited is a biotech venture specializing in the development of regenerative cell therapies. Their products show promise for treating neurological disorders.
Sector
Pharmaceuticals
SanBio Company Limited is a biotech venture primarily focused on the research and development of regenerative cell medicines. Founded in the United States, the company later expanded into Japan. Their flagship product, SB623, is an allogeneic neural regenerative cell therapy targeting central nervous system disorders. The company has submitted a regulatory application in Japan for chronic traumatic brain injury and aims to expand its indications to include stroke and intracerebral hemorrhage. SanBio possesses proprietary cell culture and manufacturing technologies and has secured product supply rights. Given SB623's strong neuroprotective properties, the company is also exploring its potential in other conditions such as retinal diseases. SanBio employs a business model that combines in-house development with licensing agreements with partner companies. The company places a strong emphasis on securing intellectual property rights and is pursuing a business strategy with global expansion in mind.